Last update:
Men's health news
Prostate cancer drug combination adds toxicity without clear benefit for tumors lacking targetable mutations
The prospective, multicenter, randomized phase 2 ZZ-FIRST clinical trial, led by the Vall d'Hebron Institute of Oncology's (VHIO) Prostate Cancer Group, evaluated the androgen receptor pathway inhibitor (ARPI) enzalutamide ...
9 hours ago
0
5
Immune proteins offer new clues to how prostate cancer could be prevented
A new study led by researchers at Oxford Population Health shows that higher levels of proteins involved in activating and coordinating the immune system were associated with a lower risk of developing prostate cancer. The ...
21 hours ago
0
34
Why obesity affects males and females differently
University of California, Riverside, scientists have an explanation for why males and females respond differently to obesity. They report in PNAS Nexus that certain immune cell populations in fat tissue may protect against ...
Nov 9, 2026
0
7
'Looksmaxxing' can include starvation, steroids and deliberate blows to the face
A rapidly growing online trend known as "looksmaxxing" may expose some boys and young men to significant physical and mental health risks, according to a new commentary published in the Journal of Adolescent Health.
Nov 9, 2026
0
6
New study identifies biological mechanism driving therapy resistance in advanced prostate cancer
A multi-institutional collaborative study led by researchers at the University of Chicago and the Fred Hutchinson Cancer Center has identified a previously unknown biological mechanism that controls cell identity and treatment ...
Nov 7, 2026
0
16
Manosphere, tobacco and gambling are driving avoidable harm and premature deaths among men, studies find
Men are suffering poor health and dying younger while the companies that profit from their misery are turning over billions of dollars.
Nov 6, 2026
0
17
Prostate cancer drug shows promise in new clinical trial
In a recent Yale-led clinical trial, a new type of prostate cancer drug showed promising results in reducing tumor activity and pain for patients with metastatic prostate cancer.
Nov 4, 2026
0
408
Women and men show similar short-term outcomes after aspiration thrombectomy for pulmonary embolism
New research presented at TCT 2026 found similar short-term outcomes in women and men with intermediate-risk pulmonary embolism (PE) after aspiration thrombectomy, a catheter-based procedure to remove blood clots from arteries ...
Nov 3, 2026
0
5
Retired NFL players, notably linemen, have high risk of artery plaque, independent study shows
Retired NFL players may have a high risk of undiagnosed, untreated coronary artery disease (CAD) that often occurs without symptoms, according to new, independent, preliminary research presented at the American Heart Association's ...
Nov 2, 2026
0
9
Researchers identify critical window for boosting immunotherapy response in prostate cancer
Researchers at Roswell Park Comprehensive Cancer Center have shown that hormone-blocking therapies commonly used to treat prostate cancers temporarily activate the body's immune response before those immune effects begin ...
Oct 29, 2026
0
11
Animal and plant proteins show different associations with testosterone levels in men
Higher animal protein intake was associated with lower blood testosterone levels, while higher plant protein intake was associated with higher levels, according to a new study from the University of Eastern Finland. The findings ...
Oct 28, 2026
0
59
Health care discrimination may silence diabetes conversations among Black men
Managing type 2 diabetes requires more than occasional visits to the doctor's office. Much of the work happens between appointments, making communication and support from others an important part of managing the condition.
Oct 28, 2026
0
7
Novel alpha radiopharmaceutical therapy shows promise in early-phase prostate cancer trial
A new alpha-emitting radiopharmaceutical therapy (RPT) for advanced prostate cancer was well tolerated, with no dose-limiting toxicities observed, and showed encouraging signs of antitumor activity, according to a trial published ...
Oct 27, 2026
0
8
Guideline on shorter-course radiation therapy for localized prostate cancer updated
An updated clinical guideline from the American Society for Radiation Oncology (ASTRO) provides evidence-based recommendations on the use of hypofractionated radiation therapy for patients with localized prostate cancer. ...
Oct 27, 2026
0
6
New treatment approach shows promise in reducing prostate cancer spread
Adding darolutamide to standard treatment for aggressive prostate cancer reduced the risk of the disease spreading in an international phase 3 trial.
Oct 26, 2026
0
63
Fewer US men are diagnosed with low-risk prostate cancer, and more of them now choose surveillance over treatment
An analysis of United States data reveals a broad shift away from overtreatment of low-risk prostate cancer. The analysis published in CANCER indicates a shift toward surveillance in response to concerns of overdiagnosis ...
Oct 26, 2026
0
57
Patients given apalutamide and hormone therapy around surgery may cut their risk of metastasis or death
An international phase 3 clinical trial that treated patients with high-risk localized and locally advanced prostate cancer with apalutamide—a next-generation neoadjuvant androgen-receptor pathway inhibitor (ARPI)—plus hormone ...
Oct 26, 2026
0
7
Adding abiraterone to ADT and docetaxel improves survival in metastatic prostate cancer
Adding abiraterone to standard treatment provides a lasting survival benefit for men whose prostate cancer has already spread at diagnosis, reinforcing the value of early treatment intensification. The findings come from ...
Oct 26, 2026
0
7
Diagnostic test could help doctors refine prostate cancer treatment
Prostate cancer is the most common cancer in men—in 2013, it affected more than 1 million men across the world. The cancer does not behave the same way in every patient, and doctors have long faced a difficult balancing act ...
Oct 23, 2026
0
360
Real-world results confirm benefit of antigen therapy for prostate cancer
Prostate-specific membrane antigen (PSMA)-targeted radiopharmaceutical therapy is safe and effective for patients with metastatic castration-resistant prostate cancer (mCRPC) in routine clinical practice, consistent with ...
Oct 23, 2026
0
11
Male breast cancer: Risk rises with age, expert explains
Male breast cancer is far less common than breast cancer in women, but it is usually discovered later: Men with breast cancer often receive the diagnosis after finding a breast lump on their own. Kathryn Ruddy, M.D., an oncologist ...
Oct 22, 2026
0
8
STI rates drop following antibiotic use recommendations for gay and bisexual men
After years of rising sexually transmitted infection (STI) rates in Australia, new Burnet Institute–led research has found promising evidence that an existing antibiotic taken after sex may be helping to reduce syphilis and ...
Oct 21, 2026
0
15
Blood proteins could reveal clues to prostate cancer risk more than a decade before diagnosis
Proteins linked to the immune system, cell adhesion, blood vessel formation and known prostate cancer genes were associated with the future risk of developing prostate cancer, including aggressive disease, in a new study ...
Oct 21, 2026
0
12
Genomic cancer driver study reveals new clues to why some prostate cancers become aggressive
Why do some prostate cancers grow slowly for years, while others progress quickly to life-threatening metastatic disease? An international team of researchers co-led by the Ontario Institute for Cancer Research (OICR) and ...
Oct 16, 2026
0
17
Low testosterone screening rates among US army personnel examined
Approximately 1 in 4 active-duty male U.S. Army personnel may have a morning testosterone measurement below a commonly used clinical threshold, according to new research from Pennington Biomedical Research Center published ...
Oct 15, 2026
0
9
